Literature DB >> 14738389

Caulibugulones A-F, novel cytotoxic isoquinoline quinones and iminoquinones from the marine bryozoan Caulibugula intermis.

Dennis J Milanowski1, Kirk R Gustafson, James A Kelley, James B McMahon.   

Abstract

An extract of the marine bryozoan Caulibugula intermis, collected in the Indo-Pacific off Palau, produced a distinct pattern of differential cytotoxicity in the National Cancer Institute's 60 cell line antitumor screen. Bioactivity-directed fractionation of the extract provided six new compounds, caulibugulones A-F (1-6). The structures of these novel metabolites were determined by spectrochemical analyses including LC-MS, HRFABMS, 1-D and 2-D NMR experiments, and by comparison with related compounds. The structures of compounds 2 and 3 were confirmed by chemical interconversion. The isolated compounds exhibited IC(50)'s of 0.03-1.67 microg/mL against murine tumor cells in an in vitro cytotoxicity assay.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14738389     DOI: 10.1021/np030378l

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  10 in total

Review 1.  Review of bioactive secondary metabolites from marine bryozoans in the progress of new drugs discovery.

Authors:  Xiang Rong Tian; Hai Feng Tang; Xiao Lin Tian; Jia Jun Hu; Li Li Huang; Kirk R Gustafson
Journal:  Future Med Chem       Date:  2018-05-23       Impact factor: 3.808

Review 2.  A Comprehensive Overview of the Developments of Cdc25 Phosphatase Inhibitors.

Authors:  Ahmed Bakr Abdelwahab; Eslam Reda El-Sawy; Atef G Hanna; Denyse Bagrel; Gilbert Kirsch
Journal:  Molecules       Date:  2022-04-07       Impact factor: 4.927

3.  Mansouramycin C kills cancer cells through reactive oxygen species production mediated by opening of mitochondrial permeability transition pore.

Authors:  Shan Kuang; Ge Liu; Ruobing Cao; Linlin Zhang; Qiang Yu; Chaomin Sun
Journal:  Oncotarget       Date:  2017-10-24

4.  Synthesis and in vitro antiproliferative activity of new phenylaminoisoquinolinequinones against cancer cell lines.

Authors:  Virginia Delgado; Andrea Ibacache; Verónica Arancibia; Cristina Theoduloz; Jaime A Valderrama
Journal:  Molecules       Date:  2013-01-08       Impact factor: 4.411

5.  Synthesis and in vitro cytotoxic evaluation of aminoquinones structurally related to marine isoquinolinequinones.

Authors:  Virginia Delgado; Andrea Ibacache; Cristina Theoduloz; Jaime A Valderrama
Journal:  Molecules       Date:  2012-06-07       Impact factor: 4.411

6.  Synthesis, half-wave potentials and antiproliferative activity of 1-aryl-substituted aminoisoquinolinequinones.

Authors:  Juana Andrea Ibacache; Virginia Delgado; Julio Benites; Cristina Theoduloz; Verónica Arancibia; Giulio G Muccioli; Jaime A Valderrama
Journal:  Molecules       Date:  2014-01-08       Impact factor: 4.411

Review 7.  The Phylum Bryozoa as a Promising Source of Anticancer Drugs.

Authors:  Blanca Figuerola; Conxita Avila
Journal:  Mar Drugs       Date:  2019-08-17       Impact factor: 5.118

8.  Synthesis of 4-(1H-isochromen-1-yl)isoquinolines through the silver-catalysed homodimerization of ortho-alkynylarylaldehydes and subsequent condensation of the 1,5-dicarbonyl motif with NH3.

Authors:  Minghui Guo; Xin Meng; Yang Zhao; Yuexia Dong; Xuejun Sun; Laijin Tian; Ziping Cao
Journal:  RSC Adv       Date:  2019-01-21       Impact factor: 4.036

9.  Unequivocal determination of caulamidines A and B: application and validation of new tools in the structure elucidation tool box.

Authors:  Dennis J Milanowski; Naoya Oku; Laura K Cartner; Heidi R Bokesch; R Thomas Williamson; Josep Saurí; Yizhou Liu; Kirill A Blinov; Yuanqing Ding; Xing-Cong Li; Daneel Ferreira; Larry A Walker; Shabana Khan; Michael T Davies-Coleman; James A Kelley; James B McMahon; Gary E Martin; Kirk R Gustafson
Journal:  Chem Sci       Date:  2017-11-06       Impact factor: 9.825

10.  Mansouramycins E-G, Cytotoxic Isoquinolinequinones from Marine Streptomycetes.

Authors:  Mohamed Shaaban; Khaled A Shaaban; Gerhard Kelter; Heinz Herbert Fiebig; Hartmut Laatsch
Journal:  Mar Drugs       Date:  2021-12-20       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.